GLOBAL BIOENERGIES SA (ALGBE.PA) Stock Fundamental Analysis
Europe • Euronext Paris • EPA:ALGBE • FR0011052257
0.0185 EUR
0 (-7.5%)
Last: Nov 28, 2025, 07:00 PM
We assign a fundamental rating of 2 out of 10 to ALGBE. ALGBE was compared to 71 industry peers in the Chemicals industry. ALGBE may be in some trouble as it scores bad on both profitability and health. ALGBE does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- In the past year ALGBE has reported negative net income.
- ALGBE had a negative operating cash flow in the past year.
- In the past 5 years ALGBE always reported negative net income.
- In the past 5 years ALGBE always reported negative operating cash flow.
1.2 Ratios
- ALGBE's Return On Assets of -60.73% is on the low side compared to the rest of the industry. ALGBE is outperformed by 94.59% of its industry peers.
- ALGBE has a worse Return On Equity (-346.31%) than 93.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -60.73% | ||
| ROE | -346.31% | ||
| ROIC | N/A |
ROA(3y)-54.57%
ROA(5y)-48.79%
ROE(3y)-195.4%
ROE(5y)-183.82%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ALGBE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- ALGBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
- The number of shares outstanding for ALGBE remains at a similar level compared to 1 year ago.
- Compared to 5 years ago, ALGBE has more shares outstanding
- The debt/assets ratio for ALGBE is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of -2.52, we must say that ALGBE is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of ALGBE (-2.52) is worse than 91.89% of its industry peers.
- ALGBE has a Debt/Equity ratio of 2.78. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of ALGBE (2.78) is worse than 93.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.78 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.52 |
ROIC/WACCN/A
WACC4.52%
2.3 Liquidity
- A Current Ratio of 2.86 indicates that ALGBE has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 2.86, ALGBE belongs to the best of the industry, outperforming 82.43% of the companies in the same industry.
- A Quick Ratio of 2.73 indicates that ALGBE has no problem at all paying its short term obligations.
- The Quick ratio of ALGBE (2.73) is better than 93.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.86 | ||
| Quick Ratio | 2.73 |
3. Growth
3.1 Past
- ALGBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.31%, which is quite impressive.
- The Revenue for ALGBE has decreased by -88.90% in the past year. This is quite bad
- ALGBE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.15% yearly.
EPS 1Y (TTM)33.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.52%
Revenue 1Y (TTM)-88.9%
Revenue growth 3Y52.9%
Revenue growth 5Y25.15%
Sales Q2Q%-85.13%
3.2 Future
- Based on estimates for the next years, ALGBE will show a decrease in Earnings Per Share. The EPS will decrease by -5.13% on average per year.
- Based on estimates for the next years, ALGBE will show a small growth in Revenue. The Revenue will grow by 0.48% on average per year.
EPS Next Y22.81%
EPS Next 2Y-5.13%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.97%
Revenue Next 2Y0.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALGBE. In the last year negative earnings were reported.
- Also next year ALGBE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ALGBE's earnings are expected to decrease with -5.13% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.13%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- ALGBE does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GLOBAL BIOENERGIES SA / ALGBE.PA FAQ
What is the fundamental rating for ALGBE stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALGBE.PA.
Can you provide the valuation status for GLOBAL BIOENERGIES SA?
ChartMill assigns a valuation rating of 0 / 10 to GLOBAL BIOENERGIES SA (ALGBE.PA). This can be considered as Overvalued.
How profitable is GLOBAL BIOENERGIES SA (ALGBE.PA) stock?
GLOBAL BIOENERGIES SA (ALGBE.PA) has a profitability rating of 0 / 10.
What is the expected EPS growth for GLOBAL BIOENERGIES SA (ALGBE.PA) stock?
The Earnings per Share (EPS) of GLOBAL BIOENERGIES SA (ALGBE.PA) is expected to grow by 22.81% in the next year.